−0.1807USD
−2.05 MUSD
6.16 M
About Accustem Sciences Inc.
Sector
CEO
Wendy Blosser
Headquarters
New York
Website
Employees (FY)
3
Founded
2020
FIGI
BBG015QPWHT9
AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. It also focuses on commercialization of a proprietary genomic test, StemPrintER, for patients with early-stage breast cancer. The company was founded by Gabriele Marco Antonio Cerrone on June 5, 2020 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ACUT is 0.3880 USD — it has increased by 40.58% in the past 24 hours. Watch Accustem Sciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Accustem Sciences Inc. stocks are traded under the ticker ACUT.
Yes, you can track Accustem Sciences Inc. financials in yearly and quarterly reports right on TradingView.
ACUT stock has risen by 40.58% compared to the previous week, the month change is a 40.58% rise, over the last year Accustem Sciences Inc. has showed a 77.83% decrease.
ACUT net income for the last quarter is −246.04 K USD, while the quarter before that showed −598.53 K USD of net income which accounts for 58.89% change. Track more Accustem Sciences Inc. financial stats to get the full picture.
No, ACUT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ACUT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Accustem Sciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of May 8, 2024, the company has 3.00 employees. See our rating of the largest employees — is Accustem Sciences Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Accustem Sciences Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Accustem Sciences Inc. stock shows the neutral signal. See more of Accustem Sciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.